Literature DB >> 32261750

Preparation of PEG-modified PAMAM dendrimers having a gold nanorod core and their application to photothermal therapy.

Xiaojie Li1, Keishi Takeda, Eiji Yuba, Atsushi Harada, Kenji Kono.   

Abstract

This study was conducted to attempt development of a new type of hybrid dendrimer consisting of a gold nanorod (GNR) core and PEG-modified PAMAM (PEG-PAMAM) dendrons by adding PEG-PAMAM G2-G4 dendrimers with a cystamine core at various timings during the GNR growing reaction. We obtained hybrids of the dendrimers and GNRs exhibiting surface plasmon resonance in the near infrared region. Whereas the PEG-PAMAM G4 dendrimer-GNR hybrid formed an aggregate in an aqueous solution, PEG-PAMAM G2 and G3 dendrimers respectively gave hybrids with average diameters of 24 nm and 31 nm. Especially, the spherical PEG-PAMAM G3 dendrimer-GNR hybrid might be regarded as a GNR-cored PEG-PAMAM dendrimer in which the GNR core was well stabilized by highly hydrated PEG-PAMAM G3 dendrons. The GNR-cored PEG-PAMAM G3 dendrimer exhibited excellent heat-generation capability under near-infrared light irradiation. Incubation with the GNR-cored PEG-PAMAM G3 dendrimer showed no damage to HeLa cells. However, dendrimer-treated cells were killed effectively by near-infrared laser irradiation, indicating excellent photothermal capability of the GNR-cored PEG-PAMAM G3 dendrimer. Furthermore, the GNR-cored PEG-PAMAM G3 dendrimer injected into mice tumor tissues significantly increased the temperature of the tumor when irradiated with near infrared light, resulting in a decreased tumor volume. These results demonstrate that GNR-cored PEG-PAMAM dendrimers might be a new nanomaterial for biomedical applications such as photothermal therapy.

Entities:  

Year:  2014        PMID: 32261750     DOI: 10.1039/c4tb00132j

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  1 in total

Review 1.  Recent progress in the applications of gold-based nanoparticles towards tumor-targeted imaging and therapy.

Authors:  Xinxin Li; Yiwei Zhang; GuangKuo Liu; Ziyi Luo; Lu Zhou; Yanan Xue; Min Liu
Journal:  RSC Adv       Date:  2022-03-08       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.